Characteristic effects of activated human protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits

Walker, 1979, The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V, Biochem. Biophys. Acta, 571, 333 Marler, 1982, Mechanism of action of human activated protein C, a thrombin-dependent anticoagulation enzyme, Blood, 59, 1067, 10.1182/blood.V59.5.1067.1067 Suzuki, 1983, Inactivation of human coagulation factor V by activated protein C, J. Biol. Chem, 258, 1914, 10.1016/S0021-9258(18)33076-X Veher, 1980, Preparation and properties of bovine factor VIII (Antihemophilic factor), Biochemistry, 19, 401, 10.1021/bi00544a001 Komoriya, 1992, Inhibitory effect of activated protein C on platelet aggregation induced by the prothrombin-converting reaction, Thrombosis Res, 67, 705, 10.1016/0049-3848(92)90074-K Sakata, 1985, Activated Protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity, 82, 1121 van Hinsbergh, 1985, Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-condition medium, Blood, 65, 444, 10.1182/blood.V65.2.444.444 Chitiakrishnamuri, 1991, Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits, J. Lab. Clin. Med, 118, 523 Horellow, 1984, Congenital protein C deficiency and thrombotic disease in nine French families, Br. Med. J, 289, 1285, 10.1136/bmj.289.6454.1285 Galdson, 1988, The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis, Thrombosis and Haemostasis., 59, 18, 10.1055/s-0038-1642558 Meiletich, 1987, Absence of thrombosis in subjects with heterozygous protein C deficiency, N. Engl. J. Med., 317, 991, 10.1056/NEJM198710153171604 Bovill, 1989, The clinical spectrum of heterozygous protein C deficiency in a large New England kindred, Blood., 73, 712, 10.1182/blood.V73.3.712.712 Kogan, 1990, Protein C decreased in experimental DIC in rats, Thrombosis Res, 57, 825, 10.1016/0049-3848(90)90041-A Takahashi, 1985, Protein C levels in disseminated intravascular coagulation and thrombotic thrombocytopenic purpura; Its correlation with other coagulation parameters, Thrombosis. Haemostasis, 54, 445, 10.1055/s-0038-1657869 Ratnoff, 1951, New methods for determination of fibrinogen in small samples of plasma, L. Lab. Clin. Med., 37, 316 Erikson, 1988, Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay, Thrombosis Res, 50, 91, 10.1016/0049-3848(88)90177-6 Stephan, 1988, Human granulocyte-macrophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes, J. Clin. Invest, 79, 1720 Paul, 1988, Tumor necrosis factor induced tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes, Blood, 72, 128, 10.1182/blood.V72.1.128.bloodjournal721128 Rana, 1988, Expression of tissue factor and factor Vlla/tissue factor inhibitor activity in endotoxin or phorbol ester stimulated U937 monocyte-like cells, Blood, 72, 259, 10.1182/blood.V71.1.259.259 Harry, 1983, The effects of antithrombin III, heparin and a novel heparinoid infused on the bleeding tendency using an experimental model in the rat, Thrombosis Res, 31, 787, 10.1016/0049-3848(83)90110-X Fagrell, 1989, Changes of activated partial thromboplastin time during constant intravenous and fixed intermittent subcutaneous administration of heparin, J. Int. Med, 225, 257, 10.1111/j.1365-2796.1989.tb00075.x Gruber, 1989, Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model, Blood, 73, 639, 10.1182/blood.V73.3.639.639 Araki, 1991, Inhibitory effects of activated protein C and heparin on thrombotic arterial occlusion in rat mesenteric arteries, Thrombosis Res, 62, 209, 10.1016/0049-3848(91)90194-2 Messmore, 1989, In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with platelets, Ann. New York Acad. Sci., 556, 217, 10.1111/j.1749-6632.1989.tb22505.x John, 1993, Inhibition of platelet function by heparin: An stiologic factor in postbypass hemorrhage, J. Thorac. Cardiovas. Surg., 105, 816, 10.1016/S0022-5223(19)34155-8 Okajima, 1990, Plasma PAI activity increases in septicemic patients with multiple organ failure, 35 Taylor, 1987, Protein C prevents the coagulation and lethal effects of Escherichia coli infusion in the baboon, J. Clin. Invest, 79, 918, 10.1172/JCI112902 Taylor, 1991, DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage, Blood, 78, 364, 10.1182/blood.V78.2.364.364